Table 2.
Demographic information and clinical data of patients in both the probiotic and nonprobiotic groups.
| Probiotic group | Nonprobiotic group | |||
|---|---|---|---|---|
| Gender | ||||
| Male | 37 | 40 | ||
| Female | 7 | 18 | ||
| Age | 55.00 ± 12.74 | 51.52 ± 13.50 | ||
| Pathogenesis | ||||
| Hepatitis | 17 | 26 | ||
| Alcoholic | 10 | 9 | ||
| Mixed Pathogenesis | 8 | 8 | ||
| unclassified | 9 | 15 | ||
| Child-pugh grade | ||||
| A | 4 | 16 | ||
| B | 25 | 28 | ||
| C | 15 | 14 | ||
| Pretreatment | Post-treatment | Pretreatment | Post-treatment | |
| WBC | 3.52(2.71-4.52) | 3.57(2.49-4.60) | 3.50(2.47-4.59) | 3.35(2.48-4.35) |
| N% | 63.03 ± 11.74 | 60.39 ± 11.19* | 63.21 ± 13.21 | 57.29 ± 12.93* |
| Hb | 110.8 ± 21.28 | 109.77 ± 21.86 | 103.81 ± 24.98 | 102.21 ± 24.22 |
| PLT | 66.50(41.00-99.75) | 68(43.25-105.00) | 64.00(45.75-108.00) | 67.50(45.75-103.25) |
| ALT | 31.85(26.55-45.95) | 23.35(18.10-36.83)*+ | 39.90(25.58-55.98) | 33.70(21.75-53.78)* |
| AST | 52.00(33.83-76.55) | 41.10(25.65-53.53)* | 57.85(41.20-77.45) | 46.35(36.18-66.28)* |
| TBIL | 39.90(28.80-59.00) | 27.80(17.75-46.78)*+ | 37.60(29.68-56.88) | 34.90(26.08-49.13)* |
| TBA | 49.40(23.98-94.75) | 45.50(19.00-77.50)* | 51.65(23.08-106.05) | 44.60(24.83-76.83)* |
*indicates a statistically significant difference between pre- and posttreatment (p < 0.05). +indicates a statistically significant difference between the probiotic and nonprobiotic groups posttreatment (p < 0.05).